Warning letter
Baxter Healthcare Corporation: warning letter of Mar 23, 2005
FDA warning letter UCM075334 · Florida District Office
Key facts
| Reference number | UCM075334 |
|---|---|
| Company | Baxter Healthcare Corporation |
| Subject | Current Good Mfg Practice Regulation/Adulterated/Misbranded |
| Issue date | Mar 23, 2005 |
| Posted date | Mar 23, 2005 |
| Issuing office | Florida District Office |
| Product type | Devices |
| CFR sections cited | 820, 803, 806, 806.10(a)(1) |
| Country | 3 |
| Inspection city | Largo |
| Inspection ZIP | 33773-5129 |
| Inspection start date | Oct 12, 2004 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: